Showing results (1061-1070 of 1,241) with videos related to

Sort By:
Pageof 125
Circulation. Heart Failure|June 18, 2013
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HFZubin J Eapen, Shelby D Reed, Yanhong Li, et al.
European Journal of Heart Failure|December 29, 2015
Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HFMarc D Samsky, Allison Dunning, Adam D DeVore, et al.
JACC. Heart Failure|December 3, 2014
Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trialW H Wilson Tang, Matthias Dupont, Adrian F Hernandez, et al.
European Heart Journal|May 21, 2023
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HFMuthiah Vaduganathan, Robert J Mentz, Brian L Claggett, et al.
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
Journal of the American Heart Association|June 22, 2023
Internet Versus Noninternet Participation in a Decentralized Clinical Trial: Lessons From the ADAPTABLE StudyRebecca Shen, Hillary Mulder, Lisa Wruck, et al.
Journal of the American College of Cardiology|May 26, 2026
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular riskKausik K Ray, Nicholas Clarke, Peter Thornton, et al.
Journal of Clinical and Translational Science|December 10, 2024
Accelerating evidence generation: Addressing critical challenges and charting a path forwardJeeyon G Rim, Jennifer G Jackman, Christoph P Hornik, et al.
JAMA Cardiology|October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JAMA Cardiology|November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialDouglas L Mann, Michael M Givertz, Justin M Vader, et al.
Pageof 125